为了充分发挥零售药店网络在疫情防控中的"哨点"监测作用，实现"早发现、早诊断、早检测、早治 疗"，佛山市市场监督管理局已决定自8月1日起全市所有零售药店实行销售重点管控药品登记报告制 度。 佛山市市场监督管理局8月1日在官网发文表示，本次纳入实名登记管理的药品主要指治疗基孔肯雅热引 起的发热、皮疹、关节痛等症状的药品，您在购买上述药品时，请配合药店工作人员，进行扫码实名验 证，并填报相关个人信息。同时如有发热、皮疹、关节痛等症状，以及近期是否有被蚊虫叮咬等信息， 请主动告知药店工作人员。 具体看，疫情期间需实名登记销售的药品共有47种（所有药品包含儿童剂型），具体包括风寒感冒颗 粒、连花清瘟胶囊（颗粒）、布洛芬（所有口服剂型）、（复方）对乙酰氨基酚（所有口服剂型）、磷 酸奥司他韦（所有口服剂型）等。 佛山方面也启用零售药店销售重点管控药品信息登记管理系统。 佛山市市场监督管理局官网截图 根据广东省疾控局最新通报，2025年7月27日0时至8月2日24时，广东全省新增报告2892例基孔肯雅热本 地病例，未报告重症和死亡病例，病例分布在佛山2770例，广州65例，东莞、中山各11例，深圳、江 门、肇庆各6例，梅州 ...

Group 1 - The article discusses the implementation of a real-name registration system for the sale of key controlled drugs in retail pharmacies in Foshan, aimed at enhancing monitoring during the epidemic [1][2] - A total of 47 types of drugs are included in the real-name registration management, which are primarily used for treating symptoms related to the Chikungunya virus, such as fever, rash, and joint pain [1] - The Guangdong Provincial Center for Disease Control reported a total of 2,892 new local cases of Chikungunya fever from July 27 to August 2, 2025, with the majority of cases concentrated in Foshan [3] Group 2 - The article highlights that the epidemic situation in Guangdong has shown signs of initial containment, with a downward trend in new cases reported during the specified week [3] - Despite the containment efforts, the risk of imported cases remains due to frequent international exchanges and the ongoing challenges posed by weather conditions that facilitate mosquito activity [3]